Fairfield, Bush & Co’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-33
Closed -$3.39K 561
2023
Q2
$3.39K Buy
+33
New +$3.39K ﹤0.01% 390
2022
Q3
Sell
-33
Closed -$3K 513
2022
Q2
$3K Buy
+33
New +$3K ﹤0.01% 385